O’Shea, Catherine J.
Brooks, Anthony G.
Middeldorp, Melissa E.
Harper, Curtis
Hendriks, Jeroen M.
Russo, Andrea M.
Freeman, James V.
Gopinathannair, Rakesh
Varma, Niraj
Deering, Thomas F.
Campbell, Kevin
Sanders, Prashanthan http://orcid.org/0000-0003-3803-8429
Article History
Received: 22 November 2022
Accepted: 14 January 2023
First Online: 3 February 2023
Change Date: 24 February 2023
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: The study was reviewed and approved by the Human Research Ethics Committees of the Central Adelaide Local Health Network and the University of Adelaide.
: Not applicable.
: Dr. Brooks is currently employed by Microport. Mr. Harper is currently employed by PaceMate. Dr. Hendriks reports that the University of Adelaide has received on his behalf lecture and/or consulting fees from Medtronic and Pfizer/BMS. Dr. Russo reports research grants from Boston Scientific and Kestra, consulting from Abbott, Boston Scientific, Medtronic and PaceMate, and honoraria from Biotronik. Dr. Freeman reports consulting/advisory board fees from Boston Scientific, Medtronic, Janssen Pharmaceuticals, Biosense Webster, and PaceMate and equity from PaceMate. Dr. Gopinathannair reports that he has received consulting fees or honoraria from Abbott Medical, Boston Scientific, Zoll Medical. Dr. Gopinathannair reports having served on the advisory board of PaceMate, and Altathera. Dr. Deering reports that Piedmont Healthcare receives on his behalf research grants from Abbott, Biotronik, Biosense Webster, Medtronic, and Milestone. He also reports that he has consulted for CVRx, PaceMate, Preventice, and Sanofi while serving as a member of an Adjudication Committee for Abbott. Dr. Varma reports having consulted for Medtronic, Abbott Medical, Boston-Scientific, Biotronik, Microport, and on the advisory board for PaceMate. Dr. Campbell was previously employed by PaceMate. Dr. Sanders reports having served on the advisory board of Medtronic, Abbott Medical, Boston-Scientific, PaceMate, and CathRx. Dr. Sanders reports that the University of Adelaide receives on his behalf lecture and/or consulting fees from Medtronic, Abbott Medical, and Boston-Scientific. Dr. Sanders reports that the University of Adelaide receives on his behalf research funding from Medtronic, Abbott Medical, Boston-Scientific, Microport, and BD. The remaining authors have nothing to disclose.